Cleared Traditional

K961123 - ALT INCORPORATING DST

K961123 is the FDA 510(k) clearance for ALT INCORPORATING DST by Trace Scientific , Ltd.. It is a Class 1 Chemistry device (product code CKA) cleared through the Traditional 510(k) pathway after a 35-day FDA review.

K961123 · Trace Scientific , Ltd. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1996
Decision
35d
Days
Class 1
Risk

K961123 is an FDA 510(k) clearance for the ALT INCORPORATING DST. Classified as Nadh Oxidation/nad Reduction, Alt/sgpt (product code CKA), Class I - General Controls.

Submitted by Trace Scientific , Ltd. (Miami, US). The FDA issued a Cleared decision on April 25, 1996 after a review of 35 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1030 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Trace Scientific , Ltd. devices

Submission Details

510(k) Number K961123 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 21, 1996
Decision Date April 25, 1996
Days to Decision 35 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
53d faster than avg
Panel avg: 88d · This submission: 35d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CKA Nadh Oxidation/nad Reduction, Alt/sgpt
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1030
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CKA Nadh Oxidation/nad Reduction, Alt/sgpt

All 98
Devices cleared under the same product code (CKA) and FDA review panel - the closest regulatory comparables to K961123.
DIMENSION VISTA ALBUMIN, ALKALINE PHOSPHATASE, ASPARTATE AMINO TRANSFERASE, CARBAMAZEPINE & ALANINE AMINO TRANSFERASE
K061020 · Dade Behring, Inc. · May 2006
ALANINE AMINOTRANSFERASE-SL ASSAY CATALOGUE NUMBER 318-10, 318-30
K974003 · Diagnostic Chemicals , Ltd. · Dec 1997
CX ALANINE, CX ASPARTATE AMINOTRANSFERASE-PYRIDOXAL-5-PHOSPHATE, CX CREATINE PHOSPHOKINASE-N-ACETYL-L-CYSTEINE
K952427 · Beckman Instruments, Inc. · Sep 1995
ALANINE AMINOTRANSFERASE REAGENT SYSTEM
K952744 · Medical Diagnostic Technologies, Inc. · Aug 1995
HICHEM ALT REAGENT KIT
K951818 · Hi Chem, Inc. · May 1995
STANBIO ALT/GPT (LUQUI-UV) TEST SET
K941314 · Stanbio Laboratory · Jul 1994